iBio, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -9.7% | +47.4% | -42.7% | -14.7% | -11.5% | -12.0% | +21.4% | +176.7% | +0.4% | +33.3% | +15.5% | |
| – | -14.4% | +83.5% | -56.6% | -25.3% | -29.2% | -26.9% | +60.4% | +422.3% | +5.1% | +44.8% | +19.4% | |
| – | +90.8% | +90.2% | +168.0% | -22.3% | -36.4% | -29.3% | +73.1% | +227.6% | +2.0% | +66.1% | +18.4% | |
| – | +90.8% | +90.2% | +168.0% | -22.3% | -36.4% | -29.3% | +73.1% | +477.6% | +6.3% | +41.9% | +17.7% | |
| – | – | +705.9% | -94.9% | – | – | – | – | -38.1% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.1% | -0.1% | -0.1% | -0.1% | +13.9% | -0.1% | +12.2% | -0.1% | -36.6% | -57.8% | -0.3% | |
| – | +1.5% | +1.9% | -70.7% | -8.7% | +15.4% | -1.0% | +7.5% | -2.3% | -3.5% | +5.9% | +61.5% | |
| – | +4.1% | -0.6% | -82.1% | -9.7% | +35.7% | +14.6% | +13.1% | -0.9% | -2.4% | +10.2% | +80.6% | |
| – | +4.0% | -3.0% | -93.0% | +0.2% | -5.3% | +58.2% | -8.5% | -7.6% | -57.2% | +2.7% | +2.6% | |
| – | -2.7% | -33.9% | -70.8% | +138.8% | -28.2% | +140.6% | +48.1% | +29.0% | -6.0% | +14.4% | +45.7% | |
| – | – | – | -7.0% | -7.8% | -8.9% | – | – | – | – | – | – | |
| – | -30.4% | +170.3% | -14.2% | -16.7% | -21.7% | -18.1% | +30.7% | +276.6% | +0.9% | +37.1% | +10.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +54.9% | +100.1% | +132.3% | +0.1% | +5.8% | +8.0% | +66.5% | +222.6% | +87.1% | +20.6% | -13.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.